NumerixS Investment Technologies Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$19,000
+90.0%
214
+114.0%
0.01%0.0%
Q1 2020$10,000
-70.6%
100
-66.7%
0.01%
-28.6%
Q4 2019$34,000
-73.0%
300
-70.0%
0.01%
-78.8%
Q3 2019$126,000
+142.3%
1,000
+66.7%
0.03%
+371.4%
Q1 2019$52,000
+420.0%
600
+500.0%
0.01%
+133.3%
Q4 2018$10,000
-75.6%
100
-72.1%
0.00%
-62.5%
Q3 2018$41,000
+78.3%
358
-10.5%
0.01%
+60.0%
Q4 2017$23,000
-72.9%
400
-78.9%
0.01%
-73.7%
Q3 2017$85,000
-51.1%
1,900
-56.8%
0.02%
-26.9%
Q2 2017$174,000
+987.5%
4,400
+1000.0%
0.03%
+1200.0%
Q4 2016$16,0004000.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders